Psychoeducation Improves Hepatitis C Virus Treatment During Opioid Substitution Therapy: A Controlled, Prospective Multicenter Trial | Zendy

Jens Reimer | Zendy; Christiane Sybille Schmidt | Zendy; Bernd Schulte | Zendy; Dirk Gansefort | Zendy; Jörg Gölz | Zendy; Guido Gerken | Zendy; Norbert Scherbaum | Zendy; Uwe Verthein | Zendy; Markus Backmund | Zendy

Open Access

Psychoeducation Improves Hepatitis C Virus Treatment During Opioid Substitution Therapy: A Controlled, Prospective Multicenter Trial

Author(s) -

Jens Reimer,

Christiane Sybille Schmidt,

Bernd Schulte,

Dirk Gansefort,

Jörg Gölz,

Guido Gerken,

Norbert Scherbaum,

Uwe Verthein,

Markus Backmund

Publication year - 2013

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cit307

Subject(s) - medicine , hepatitis c virus , opiate substitution treatment , psychosocial , psychoeducation , hepatitis c , methadone , randomized controlled trial , multicenter trial , opioid , virus , multicenter study , buprenorphine , virology , psychiatry , receptor , intervention (counseling)

People who inject drugs (PWID) have a high prevalence of hepatitis C virus (HCV) infection. However, PWID are considered "difficult to treat," requiring a specifically adapted treatment setting, including psychosocial support.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research